Cannabis in Germany

Cannabis in Germany

In 2024, Germany has legalised cannabis consumption. Since cannabis is not listed as a narcotic drug anymore, access to medical cannabis has become easier too. Despite the legalisation aimed at combating the illicit market, the absence of legal production facilities and/or an infrastructure for cannabis distribution forces consumers to continue buying via the black market. As the economy is not performing well and people are generally unsatisfied with the “traffic-light” coalition, the next gove...

Euromonitor International's Cannabis in Germany market report offers a comprehensive guide to the size and shape of this emerging market opportunity at a national level. It provides the latest retail sales data (historic date range), allowing you to identify the key cannabinoid categories driving growth. It outlines the regulatory, cultural and commercial context and offers strategic analysis of key factors influencing the market – legislative developments both current and future, economic/lifestyle influences, illicit consumption, product innovation, distribution and pricing trends. Forecasts to 2029 illustrate how the market is set to expand and change.

Product coverage: Adult-Use Cannabis, CBD & Other Non-Intoxicating Cannabinoids, Medical Cannabis.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report??
* Get a detailed picture of the Cannabis market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.